Viewing Study NCT00282659



Ignite Creation Date: 2024-05-05 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00282659
Status: COMPLETED
Last Update Posted: 2019-05-21
First Post: 2006-01-25

Brief Title: The Use of Magnesium to Improve Blood Pressure Cholesterol and Glucose Control
Sponsor: Hartford Hospital
Organization: Hartford Hospital

Study Overview

Official Title: The Use of Magnesium to Improve Hemodynamics Cholesterol and Glucose Control A Substudy of AdMag
Status: COMPLETED
Status Verified Date: 2019-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine if magnesium can improve blood pressure cholesterol and blood sugar control in patients with implantable cardioverter defibrillators ICDs
Detailed Description: Magnesium is the second most abundant intracellular cation and plays a vital role in many physiologic processes It has been determined that patients with cardiovascular disease have intracellular magnesium Mgi deficiencies Among the ICD registries in Europe and the United States 64 and 77 of patients also carry the diagnosis of CAD respectively Patients with CAD have risk factors that lead to the development and or propagation of atherosclerosis Paramount among these risk factors are hypertension dyslipidemia and diabetes

Comparison Magnesium compared to placebo in patients with ICDs to evaluate the effect they have on cholesterol blood pressure and blood glucose

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None